The University of Pennsylvania Medical Scientist Training Program provides support for both MD-PhD and VMD-PhD trainees and is currently in its 37th year of funding. The primary goal of the program is to identify, train and mentor a diverse group of outstanding men and women who will become the leaders of biomedical human and veterinary research, as well as teachers and scholars. To accomplish this goal, we have established flexible training plans that emphasize the integration of the professional and research degrees in preparation for careers that will make use of both. The large institutional commitment to this goal is reflected by the investment that the medical and veterinary schools have made in this program, providing it with resources that are used to help cover tuition and stipend costs, maintain enrichment activities, and support administration of the program. There are currently 220 combined degree students (185 MD-PhD and 25 VMD-PhD), all of whom are fully funded. Admission is open to recent college graduates and to current Penn MD, VMD and PhD students. Selection emphasizes academic excellence, research experience, creativity, letters of recommendation and a well-articulated plan for a career in research. Most trainees do graduate work in the biomedical sciences, but 17% are currently taking advantage of the breadth of opportunities offered by a large university by enrolling in graduate programs in Biomedical Engineering, Physics, Health Care Economics, History &Sociology of Science, Medical Anthropology, Urban Design, and Epidemiology. The proposed training faculty reflects this diversity of interests. It includes 147 senior and junior PhD, MD-PhD and MD investigators in departments, centers and institutes spread across Penn's campus. As of June 2011, there have been 442 MD-PhD and 63 VMD-PhD graduates since program inception. 76% of MD-PhD alumni and 87% of VMD-PhD alumni who have completed postgraduate training are employed by academic centers, research institutes, the biotech and pharmaceutical industries or federal agencies. Many have NIH or other extramural funding for their research. The average time to completion for recent graduates in both programs has been 8 years. The attrition rate for the past 10 years has been low: 4% in the MD-PhD program and 8% in the VMD-PhD program. Specific goals for the next 5 years include 1) continued growth to achieve at least 200 MD-PhD and 30 VMD-PhD students, 2) expanded partnerships with additional graduate programs at Penn, 3) further integration of the graduate and professional degrees, 4) reducing time to degree without compromising training, and 5) attracting and training a diverse group of individuals who will be prepared for the discovery and application of new knowledge through basic, translational and patient-oriented research.
As the pace at which biomedical research advances increases, there is a greater need than ever for physicians and veterinarians who are trained investigators, working at the intersection between medicine and science. The goal of the Medical Scientist Training Program at the University of Pennsylvania is to identify, train and mentor a diverse group of outstanding men and women and to help them become teachers, scholars, and leaders of biomedical research that is relevant to the full spectrum of human and animal disease.
|Mellis, Ian A; Gupte, Rohit; Raj, Arjun et al. (2017) Visualizing adenosine-to-inosine RNA editing in single mammalian cells. Nat Methods 14:801-804|
|Shanmugan, Sheila; Loughead, James; Cao, Wen et al. (2017) Impact of Tryptophan Depletion on Executive System Function during Menopause is Moderated by Childhood Adversity. Neuropsychopharmacology 42:2398-2406|
|Shanmugan, Sheila; Loughead, James; Nanga, Ravi Prakash Reddy et al. (2017) Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties. Neuropsychopharmacology 42:437-445|
|Brandstadter, Joshua D; Chen, Huiyao; Jiang, Songfu et al. (2017) IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K/GSK-3 pathway. J Leukoc Biol 101:1317-1323|
|Kalbasi, Anusha; Komar, Chad; Tooker, Graham M et al. (2017) Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 23:137-148|
|Thalji, Nabil K; Camire, Rodney M (2017) Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding. Curr Opin Hematol 24:453-459|
|Poleshko, Andrey; Shah, Parisha P; Gupta, Mudit et al. (2017) Genome-Nuclear Lamina Interactions Regulate Cardiac Stem Cell Lineage Restriction. Cell 171:573-587.e14|
|Tang, Sheng; Wang, I-Ting Judy; Yue, Cuiyong et al. (2017) Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice. J Neurosci 37:7420-7437|
|Loy, Dorothy E; Liu, Weimin; Li, Yingying et al. (2017) Out of Africa: origins and evolution of the human malaria parasites Plasmodium falciparum and Plasmodium vivax. Int J Parasitol 47:87-97|
|Thalji, Nabil K; Ivanciu, Lacramioara; Davidson, Robert et al. (2016) A rapid pro-hemostatic approach to overcome direct oral anticoagulants. Nat Med 22:924-32|
Showing the most recent 10 out of 276 publications